Le Lézard
Classified in: Health
Subjects: NPT, PER, DIS, DEI

The Anixter Center Appoints Samantha Handley as New CEO


CHICAGO, Oct. 4, 2022 /PRNewswire/ -- Lester and Rosalie Anixter Center announced today that Samantha Handley has been appointed new CEO of the company. An experienced business leader, Samantha Handley will succeed Rebecca Clark and assume responsibilities on October 4, 2022.

Handley most recently served as President and CEO of Trilogy Inc., a leader in the delivery of behavioral health services to over 3,000 clients annually. Her expertise in mental health arena spans over 20 years. Handley is a Licensed Clinical Professional Counselor and a Certified Supervisor Alcohol and Drug Counselor.

"After a thorough search of qualified candidates, led by Montague and Associates and our Board of Directors, we are excited to welcome Samantha Handley to the Lester and Rosalie Anixter Center. Samantha is a decisive leader and her expertise in driving quality outcomes and new streams of revenue is a winning combination for Anixter's next chapter," says Mary McDonnell, Board of Directors Chairperson.

"I am honored to join The Lester and Rosalie Anixter Center and appreciate the work done across our Chicago communities to provide essential services for people who are Deaf, DeafBlind and Hard of Hearing, people with disabilities, and people with mental health needs so they have the opportunity to thrive," said Handley. "I am an optimist, and believe disruption provides new opportunities for growth, innovation, and impact. I look forward to working with the Board and Anixter's talented team of employees to continue building on the great foundation in place and remain focused on growth and providing the best possible client and employee outcomes."

Samantha is a Graduate of the National Council on Behavioral Healthcare's Executive Leadership Program and holds a Master's Degree in Counseling from West Virginia University, and a Bachelor's Degree in the Science of Psychology from the University of Pittsburgh.

About Lester and Rosalie Anixter Center

Lester and Rosalie Anixter Center (Anixter Center), an innovative not-for-profit, community-based organization serves more than 5,000 people annually throughout the Chicago metropolitan area. Anixter represents people with disabilities, mental health needs, and people who are Deaf, DeafBlind, and Hard of Hearing through 30+ programs. At Anixter we envision inclusive communities where all people thrive. For more information about Anixter Center, visit www.anixter.org or join us on Facebook (Anixter Center) or Instagram (@AnixterCenter).

SOURCE Anixter Center


These press releases may also interest you

at 21:00
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

at 20:05
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

at 20:00
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

at 19:30
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...

at 19:25
Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company's breakthrough RESILIA tissue technology, designed to extend the valve's durability.*...

at 19:20
DaVinci Laboratories, a division of FoodScience, LLC of Williston, Vermont is recalling 72 bottles of Amyloid Complete because it may contain undeclared shellfish (Shrimp and Crab). People who have an allergy or severe sensitivity to shellfish run...



News published on and distributed by: